Corticosteroids, statins, macrolides, and toll-like receptor antagonists are all promising therapy possibilities [23]
That means the body burns fewer calories at rest, so when an individual stops taking a GLP-1 drug, they are likely to gain back fat mass rather than lean (i.e
While increased adiposity (i.e., overweight and obesity) is the usual driver of IR, other factors may play a role in the development of IR in T1D
R For example, sulfation of hydroxymethyl polycyclic aromatic hydrocarbons generates highly reactive sulfo-conjugates that bind DNA and initiate carcinogenesis
Preisig M, Fenton BT, Matthey ML, Berney A, Ferrero F (1999)
Wang H, Li L, Qin LL et al (2018) Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency